Articles with "radio immunotherapy" as a keyword



Photo by bermixstudio from unsplash

Radionuclide-Labeled Microspheres for Radio-immunotherapy of Hepatocellular Carcinoma.

Sign Up to like & get
recommendations!
Published in 2023 at "Advanced healthcare materials"

DOI: 10.1002/adhm.202300944

Abstract: Brachytherapy, including radioactive seed implantation (RSI) and transarterial radiation therapy embolization (TARE), is an important treatment modality for advanced hepatocellular carcinoma (HCC), but the inability of RSI and TARE to treat tumor metastasis and recurrence… read more here.

Keywords: immunotherapy; hepatocellular carcinoma; rsi; radio immunotherapy ... See more keywords
Photo from wikipedia

Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy.

Sign Up to like & get
recommendations!
Published in 2022 at "ACS nano"

DOI: 10.1021/acsnano.2c04982

Abstract: Biomaterial-based pleiotropic immune activation may effectively improve the response rate of immunotherapy and enhance the therapeutic effect of the tumor. Bacteria as a natural carrier have demonstrated great advantages in tumor targeted delivery and immune… read more here.

Keywords: pleiotropic; immunotherapy; bacterial vectors; radio immunotherapy ... See more keywords
Photo from wikipedia

MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?

Sign Up to like & get
recommendations!
Published in 2020 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2020.615697

Abstract: During the last years, preclinical and clinical studies have emerged supporting the rationale to integrate radiotherapy and immunotherapy. Radiotherapy may enhance the effects of immunotherapy by improving tumor antigen release, antigen presentation, and T-cell infiltration.… read more here.

Keywords: radio immunotherapy; guided radiotherapy; immunotherapy; radiotherapy ... See more keywords
Photo by anniespratt from unsplash

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

Sign Up to like & get
recommendations!
Published in 2022 at "Diagnostics"

DOI: 10.3390/diagnostics12051027

Abstract: Introduction: Curatively intended chemo-radio-immunotherapy for non-small cell lung cancer (NSCLC) stage III may lead to post-therapeutic pulmonary function (PF) impairment. We hypothesized that the decrease in global PF corresponds to the increase in tissue density… read more here.

Keywords: chemo radio; non small; dlco; radio immunotherapy ... See more keywords
Photo by jonathanvez from unsplash

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy

Sign Up to like & get
recommendations!
Published in 2018 at "International Journal of Oncology"

DOI: 10.3892/ijo.2018.4364

Abstract: CD44v6 is overexpressed in a variety of cancers, rendering it a promising target for radio-immunotherapy (RIT). In this study, we have characterized a novel engineered recombinant monoclonal anti-CD44v6 antibody, AbN44v6, and assessed its potential for… read more here.

Keywords: radio immunotherapy; cd44v6; antibody; abn44v6 ... See more keywords